Combining pharmacotherapy and psychotherapy in the treatment of patients with eating disorders (Q34287969)

1 August 2017

1 reference

title

Combining pharmacotherapy and psychotherapy in the treatment of patients with eating disorders (English)

1 reference

1 August 2017

0 references

1 reference

Mitchell JE

1

1 reference

1 August 2017

Peterson CB

series ordinal

2

1 reference

1 August 2017

Myers T

series ordinal

3

1 reference

1 August 2017

Wonderlich S

series ordinal

4

1 reference

1 August 2017

publication date

1 June 2001

1 reference

Psychiatric Clinics of North America

1 August 2017

published in

1 reference

1 August 2017

volume

24

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

315-323

1 reference

Outcome predictors for the cognitive behavior treatment of bulimia nervosa: data from a multisite study

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Does Fluoxetine Augment the Inpatient Treatment of Anorexia Nervosa?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Treatment of bulimia with desipramine: a double-blind crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Long-term mortality in anorexia nervosa. A 20-year follow-up of the St George's and Aberdeen cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Prior treatment received by patients with bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

A placebo-controlled trial of d-fenfluramine in bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Psychotherapy and bulimia nervosa. Longer-term effects of interpersonal psychotherapy, behavior therapy, and cognitive behavior therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Three psychological treatments for bulimia nervosa. A comparative trial

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

A comparison of two psychological treatments for bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

A prospective study of outcome in bulimia nervosa and the long-term effects of three psychological treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specific psychopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Controlled trial of psychotherapy for bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

The heterogeneity of anorexia nervosa. Bulimia as a distinct subgroup

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Comparison of cognitive-behavioral and supportive-expressive therapy for bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

A randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: Short-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Treating bulimia with desipramine. A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Naltrexone and bulimic symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Naltrexone reverses bulimic symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Treatment of antidepressant-resistant bulimia with naltrexone

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Long-term outcome of bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Bulimia nervosa, binge eating, and psychogenic vomiting: a controlled treatment study and long term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Comparison of cognitive-behavior therapy and desipramine in the treatment of bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Electrolyte and other physiological abnormalities in patients with bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Utilization of empirically supported psychotherapy treatments for individuals with eating disorders: A survey of psychologists

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Bulimia treated with imipramine: a placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Bulimia nervosa: an ominous variant of anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Bulimia nervosa: a placebo controlled double-blind therapeutic trial of mianserin

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

The long-term course of severe anorexia nervosa in adolescents: Survival analysis of recovery, relapse, and outcome predictors over 10-15 years in a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Mortality in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Long-term outcome of antidepressant treatment for bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Treatment of bulimia with phenelzine. A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Medication and psychotherapy in the treatment of bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Cognitive-behavioral treatment with and without response prevention for bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Cognitive-behavioral treatment of bulimia nervosa: a controlled evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Cognitive-behavioral and response-prevention treatments for bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Comparison of two group treatments for bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Exposure plus response-prevention treatment of bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

Cognitive-behavioral therapy for bulimia: an initial outcome study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970227-6

7 January 2021

10.1016/S0193-953X(05)70227-6

Identifiers

DOI

1 reference

1 August 2017

1 reference